March trading has started with a bang. The Dow closed down 400 points today after two big events. President Trump announced tariffs on steel and aluminum and the new Fed Chair, Jerome Powell, testified in front of the Senate Finance Committee.
Chad Leat is a former Citigroup and JPMorgan Chase executive. Leat joins Cheddar to break down the market movement and recent volatility.
When asked about President Trump's announcement about tariffs, Leat says good and fair trade traffics make for good politics, but willy-nilly tariffs are bad policy.
When it comes to the current state of the market, Leat says everyone has the same worry in their mind, inflation.
Leat says the highs the market saw in January were not sustainable. He explains the daily ups and downs of the market tend to freak people out, especially when they go down. But Leat encourages investors to try to look at the overall market and understand the full market. Leat says it is still a good time to be in the market, longterm.
We spoke with a farmer about how tariffs, trade policy, drought, and packer consolidation are reshaping the economics of American ranching and farming.
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.
Dan Niles, Founder and Portfolio Manager at Niles Investment Management, breaks down NVIDIA’s blowout earnings, 70% growth forecast and AI spending boom.
Edwin Cywinski, CEO of SunScout Holding Limited, explains how solar-powered robotic mowers are transforming lawn care and the company’s plans to scale.
Nathan Bomey, Business Reporter at Axios and author of The Axios Closer newsletter, explains why Wall Street is turning NVIDIA’s AI chips into financial assets.
Jamie Siminoff, Founder and Chief Inventor of Ring, explains the company’s new TAKE encryption standard and its push to put privacy and video data control first
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.
